submitted_tangent_copy_numbers,analyte_quantity,marital_status,haart_treatment_indicator,number_of_cycles,oxygen_use_type,eye_color,alcohol_drinks_per_day,treatment_or_therapy,blood_test_normal_range_lower,additional_pathology_findings,copy_number_variation_workflows,enneking_msts_stage,channel,expression_analysis_workflows,msi_score,samples,bone_marrow_malignant_cells,tumor_depth,spindle_cell_percent
0.85,2.5,Divorced,No,1,Continuous,Amber,0.0,no,4.5,Asbestos bodies,Whole Genome Sequencing Analysis,Not Reported,Green,RNA-Seq data analysis,0.5,Tumor biopsy,No,1.2,5.2
1.02,4.0,Domestic Partnership,Not Reported,2,Intermittent,Blue,0.5,not reported,135.0,Bilateral ovaries with endometriotic cyst and surface adhesions,Targeted Sequencing Analysis,Stage IA,Red,Differential gene expression analysis,1.2,Blood sample,Not Reported,3.5,12.8
0.92,1.2,Married,Unknown,3,Intermittent,Brown,1.0,unknown,3.5,Bone marrow concordant histology,Comparative Genomic Hybridization,Stage IB,Red,Single-cell RNA sequencing (scRNA-seq) analysis,2.8,Saliva,Unknown,0.8,23.4
1.15,0.8,Never Married,Yes,4,Continuous,Gray,1.5,yes,12.0,Clostridioides difficile (c. diff),SNP Array Analysis,Stage IIA,Green,Gene set enrichment analysis (GSEA),3.4,Bone marrow aspirate,Yes,6.7,7.9
0.78,3.6,Separated,No,5,Intermittent,Green,2.0,yes,70.0,Diffuse and early nodular diabetic glomerulosclerosis,Multiplex Ligation-dependent Probe Amplification,Stage IIB,Green,Pathway analysis,4.1,Pleural fluid,Not Reported,2.4,34.1
1.08,5.1,Widowed,Not Reported,6,Intermittent,Hazel,2.5,unknown,2.1,Dysplasia; high grade,Quantitative PCR,Stage III,Green,Microarray data analysis,5.7,Ascites fluid,Yes,4.9,45.5
0.99,0.5,Domestic Partnership,No,8,Intermittent,Not Reported,3.0,unknown,11.0,Epithelial hyperplasia,Digital PCR,Unknown,Green,Protein expression profiling,6.3,Cerebrospinal fluid,Not Reported,8.3,16.7
1.2,2.0,Married,Not Reported,10,Intermittent,Other,3.5,yes,4.2,Keratinizing dysplasia; severe (carcinoma in situ),Breakpoint Analysis,Stage IA,Green,Chromatin immunoprecipitation sequencing (ChIP-seq) analysis,7.0,Urine,Yes,5.1,29.3
0.88,4.5,Divorced,No,12,Intermittent,Red & Violet,4.0,unknown,13.5,Other Complex Extravascular Matrix Patterns,Fluorescence In Situ Hybridization,Stage IIA,Green,Whole genome sequencing (WGS) analysis,8.5,Stool,No,7.6,38.6
1.05,1.8,Married,No,15,Intermittent,Gray,4.5,unknown,40.0,Platinum-resistant,Single-Cell Sequencing Analysis,Stage III,Green,Metabolomic profiling,9.2,Skin biopsy,Not Reported,9.0,9.4
0.95,3.2,Domestic Partnership,No,18,Continuous,Amber,5.0,unknown,0.8,Dysplasia; high grade,Chromosome Conformation Capture,Stage III,Green,miRNA expression analysis,10.6,Liver biopsy,Yes,10.5,51.2
1.1,6.0,Married,No,20,Intermittent,Gray,6.0,unknown,150.0,Clostridioides difficile (c. diff),Optical Genome Mapping,Stage IA,Green,Quantitative real-time PCR (qRT-PCR) analysis,11.4,Lung biopsy,Yes,12.8,60.8
0.8,0.3,Divorced,No,24,Intermittent,Brown,7.0,unknown,5.0,Diffuse and early nodular diabetic glomerulosclerosis,RNA Sequencing,Unknown,Green,Mass spectrometry data analysis,12.8,Breast tissue,Yes,14.3,18.5
1.25,5.5,Married,Not Reported,30,Intermittent,Hazel,8.0,unknown,7.35,Dysplasia; high grade,CRISPR-Cas9 Screening,Unknown,Green,Epigenetic modification analysis,13.5,Lymph node biopsy,Yes,15.7,27.7
0.9,7.2,Separated,Not Reported,36,Continuous,Red & Violet,10.0,unknown,97.0,Dysplasia; high grade,Bioinformatics Pipeline for CNV Detection,Stage IA,Red,Transcriptome assembly and annotation,14.9,Fine needle aspirate,Not Reported,11.2,43.9
